A Phase II, prospective, multi-center, single masked, randomized, controlled, study to determine the efficacy and safety of dexamethasone ophthaLmic suspension Eye drOps in uveitic and Post-surgicAl maculaR eDema: The LEOPARD Study (ARVO 2024) - Apr 15, 2024 - Abstract #3127 - A0391; Pres time: May 7, 2024; 08:30 AM - 10:15 AM; Location: Exhibit Hall - Seattle Convention Center; A0391; "OCS-01 up to 6 drops daily has been well tolerated by subjects with CME who have received OCS-01 treatment. The ongoing study will examine the efficacy and safety of OCS-01. Layman Abstract (optional): Provide a 50-200 word description of your work that non-scientists can understand."
Clinical • P2 data • Macular Edema • Ocular Inflammation • Ophthalmology • Uveitis
|
|
Hareem Khan1; Muhammad Sohail Halim1; Chris Or1; Robert Wang2; Victor H. Gonzalez3; Edmund Tsui4; Pouya Dayani5; Quan Dong Nguyen1
|